Trastuzumab(Henlius®) Combined With Pertuzumab(Perjeta®) and Chemotherapy in Chinese Patients With Her2-Positive Metastatic Breast Cancer Previously Treated With Trastuzumab

NCT05188495 · clinicaltrials.gov ↗

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

HER2-positive Metastatic Breast Cancer
Previously Treated With Trastuzumab
Trastuzumab Combined With Pertuzumab and Chemotherapy

Interventions

DRUG: trastuzumab(Henlius®) combined with Pertuzumab(Perjeta®) and Chemotherapy

Sponsor

Peking University Cancer Hospital & Institute